148.67 USD
↗ 1.16 (0.79%)PRE MARKET (AS OF 09:22 AM EDT)
Gilead Sciences Inc
GILDNASDAQ • USD
Market: OPEN
Gilead Sciences Inc (GILD) trades at $148.67 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place GILD at a fair price relative to peers.
Technical & fundamental data as of Oct 1, 2026.
Open?$147.85
High?$149.00
Low?$147.30
Prev. Close?$147.50
Volume?72.0K
Avg. Volume?5.7M
VWAP?$147.82
Rel. Volume?0.01x
Bid / Ask
Bid?$140.69 × 100
Ask?$156.98 × 100
Spread?$16.29
Midpoint?$148.83
Valuation & Ratios
Market Cap?182.9B
Shares Out?1.2B
Float?1.2B
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?15.46
EPS?-$2.61
Dividend?2.22%
Ex-Dividend?N/A
News
Profile
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Themes
Employees
17.0K
Market Cap
182.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1992-01-22
Address
333 LAKESIDE DR
FOSTER CITY, CA 94404
Phone: (650) 574-3000
FOSTER CITY, CA 94404
Phone: (650) 574-3000
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?84
Momentum?33
Short Sent.?68
Piotroski F-Score?3/9Weak
Altman Z-Score?3.50Safe
Confidence?66%Moderate
Short InterestModerate
Short % of Float?1.48%Low
Short Interest?18.3M
Days to Cover?3.7
Free Float1.2B
Avg Daily Volume5.0M
Settlement Date2026-09-15
Financial Health
Current Ratio?1.27Adequate
Quick Ratio?1.09Adequate
Cash Ratio?0.29Low
Debt/Equity?2.22High
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score53/100
P/E?N/A▾
P/B?15.46HIGH▾
Peers20
S&P11
P/S?6.00FAIR▾
Peers55
S&P22
P/FCF?14.1CHEAP▾
Peers89
S&P77
EV/EBITDA?63.8HIGH▾
Peers11
S&P3
EV/Sales?6.76HIGH▾
Peers55
S&P22
Returns & Efficiency
ROE?-27.4%WEAK▾
Peers13
S&P6
ROA?-6.6%WEAK▾
Peers11
S&P3
Cash Flow & Enterprise
FCF?$12.9B
Enterprise Value?$206.0B
Fundamentals ratios updated end of day